Study of the Ventura device for advanced heart failure
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a device called the Ventura IASD, which is implanted in the heart to relieve pressure and help with advanced heart failure symptoms. It is for people who are already scheduled to get this device and who have moderate symptoms despite taking heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a weakened heart pump (ejection fraction of 40% or less).
- You have had heart failure for at least 6 months, and have been on stable heart medications for at least 3 months.
- Your symptoms are moderate, meaning you are comfortable at rest but get breathless or tired with mild activity (NYHA Class III).
- A blood test shows a high level of a protein called NT-proBNP (over 1,200 pg/ml), which is a sign of heart strain.
- You are 18 years or older, can attend follow-up visits, and are suitable for an MRI scan.
- You are already scheduled to receive a device called the Ventura IASD, which is a small implant that helps reduce pressure in the heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that creates a small shunt (passage) in the heart to help relieve pressure and improve symptoms in people with heart failure and a weak heart pump. The goal is to see if the device is safe and helpful for patients like you.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This study tests a new device (the VentriCure) that temporarily helps your heart pump during a stent procedure. It is for people with heart failure and blocked arteries who are at high risk for bypass surgery.
This trial uses a special heart MRI to create pressure-volume loops in people with heart failure who have a normal pumping strength (ejection fraction of 50% or higher). It aims to better understand heart function and could help guide future treatments. You may qualify if you have heart failure symptoms and specific heart structure or function changes.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.